Fifth disease: Difference between revisions
Jump to navigation
Jump to search
m (Changes made per Mahshid's request) |
No edit summary |
||
| Line 6: | Line 6: | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}{{F.Z}} | ||
{{SK}} Erythema infectiosum; parvovirus B19 infection; slapped cheek syndrome; human parvovirus B19 | {{SK}} Erythema infectiosum; parvovirus B19 infection; slapped cheek syndrome; human parvovirus B19 | ||
Latest revision as of 23:14, 22 July 2021
|
Fifth disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fifth disease On the Web |
|
American Roentgen Ray Society Images of Fifth disease |
This page is about clinical aspects of the disease. For microbiologic aspects of the causative organism(s), see Parvovirus B19.
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]Fizza Zulfiqar, MD[3]
Synonyms and keywords: Erythema infectiosum; parvovirus B19 infection; slapped cheek syndrome; human parvovirus B19
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Fifth Disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies